DERMOSCRIBE PSORIASIS- liquor carbonis detergens, salicylic acid cream 
DERMOSCRIBE PTY LTD

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DERMOSCRIBE - PSORIASIS CREAM, 69683-201

ACTIVE INGREDIENTS

LIQUOR CARBONIS DETERGENS 5%, Salicylic Acid 3%

PURPOSE

TREATMENT OF PSORIASIS.

USE

Dermoscribe's Psoriasis Cream is a topical treatment for relief of Psoriasis.

WARNINGS

FOR EXTERNAL USE ONLY. 

Seek medical advice before using if pregnant or breastfeeding. If irritation
develops, stop using and seek medical advice. May not be as effective after expiry date.

KEEP OUT OF REACH OF CHILDREN.

DIRECTIONS

For use only by persons over 12 years old. Apply in a thin layer over the affected area once or twice daily as required.

Use only in accordance with the directions on the label and within the packaging. Refer to enclosed leaflet for detailed directions.

INACTIVE INGREDIENTS

AQUEOUS CREAM

STORE AT ROOM TEMPERATURE

Dermoscribe Psoriasis Cream

DERMOSCRIBE PSORIASIS 
liquor carbonis detergens, salicylic acid cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69683-201
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
COAL TAR (UNII: R533ESO2EC) (COAL TAR - UNII:R533ESO2EC) COAL TAR5 g  in 100 g
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID3 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
CARBOMER HOMOPOLYMER TYPE C (UNII: 4Q93RCW27E)  
MINERAL OIL (UNII: T5L8T28FGP)  
GLYCOL STEARATE (UNII: 0324G66D0E)  
SORBITOL (UNII: 506T60A25R)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
GLYCERIN (UNII: PDC6A3C0OX)  
COCONUT OIL (UNII: Q9L0O73W7L)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69683-201-1160 g in 1 BOTTLE; Type 0: Not a Combination Product02/21/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H02/21/2016
Labeler - DERMOSCRIBE PTY LTD (742164734)

Revised: 1/2022
 
DERMOSCRIBE PTY LTD